Literature DB >> 16174899

Continuous antibiotic prophylaxis and cerebral spinal fluid infection in patients with intracranial pressure monitors.

John J Flibotte1, Kim En Lee, Walter J Koroshetz, Jonathan Rosand, Colin T McDonald.   

Abstract

INTRODUCTION: Inconsistencies in the recommendation of prophylactic antibiotics for patients with intracranial pressure monitors compelled us to assess the effect of our standard regimen of continuous antibiotic prophylaxis on cerebrospinal fluid infection. We examined the rate, possible risk factors, causative organisms, and characteristics of infection.
METHODS: Three hundred eleven patients admitted between September 1998 and February 2001 with an intracranial pressure monitoring device in place were included. Two hundred eleven patients received a ventriculostomy, 95 an intraparenchymal fiber optic intracranial pressure monitor (ICPM), and 5 both an ICPM and a ventriculostomy.
RESULTS: The overall infection rate was 5.5% (17/311). No patient with an ICPM developed CSF infection. The infection rate among ventriculostomy patients was 8.1% (17/211). The majority of infections (82%) were caused by Gram-positive species. Younger age (OR=1.04 for each year, 95% CI=1.01-1.08, p=0.03) and increasing duration of ventriculostomy insertion (OR=1.2 for each day of catheter insertion, 95% CI=1.1-1.3, p<0.001) were risk factors for CSF infection in multivariate analysis. Infected patients experienced longer lengths of stay in the NICU (p<0.001) and hospital (p<0.001); however, infection did not impact clinical outcome, as measured by mortality and discharge GCS.
CONCLUSION: ICP monitors have a low overall infection rate. When infection occurs, gram positive organisms predominate. For patients with ventriculostomy, duration of catheter insertion strongly predicts infection, but did not alter in-hospital mortality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16174899     DOI: 10.1385/NCC:1:1:61

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  26 in total

1.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.

Authors:  D C Classen; R S Evans; S L Pestotnik; S D Horn; R L Menlove; J P Burke
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

2.  Infections complicating the use of external ventriculostomy.

Authors:  R W Smith; J F Alksne
Journal:  J Neurosurg       Date:  1976-05       Impact factor: 5.115

Review 3.  Spread of vancomycin-resistant enterococci: why did it happen in the United States?

Authors:  W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1998-08       Impact factor: 3.254

4.  Infections related to intracranial pressure monitoring.

Authors:  E Z Franges; M E Beideman
Journal:  J Neurosci Nurs       Date:  1988-04       Impact factor: 1.230

5.  Relative risks of ventriculostomy infection and morbidity.

Authors:  C G Paramore; D A Turner
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

6.  Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients.

Authors:  K L Holloway; T Barnes; S Choi; R Bullock; L F Marshall; H M Eisenberg; J A Jane; J D Ward; H F Young; A Marmarou
Journal:  J Neurosurg       Date:  1996-09       Impact factor: 5.115

7.  Prolonged external ventricular drainage with percutaneous long-tunnel ventriculostomies.

Authors:  R K Khanna; M L Rosenblum; J P Rock; G M Malik
Journal:  J Neurosurg       Date:  1995-11       Impact factor: 5.115

8.  ICP monitoring: complications and associated factors.

Authors:  M J Rosner; D P Becker
Journal:  Clin Neurosurg       Date:  1976

9.  Continuous-pressure controlled, external ventricular drainage for treatment of acute hydrocephalus--evaluation of risk factors.

Authors:  U Bogdahn; W Lau; W Hassel; G Gunreben; H G Mertens; A Brawanski
Journal:  Neurosurgery       Date:  1992-11       Impact factor: 4.654

10.  Duration of intracranial pressure monitoring does not predict daily risk of infectious complications.

Authors:  J A Winfield; P Rosenthal; R K Kanter; G Casella
Journal:  Neurosurgery       Date:  1993-09       Impact factor: 4.654

View more
  5 in total

1.  Risk of Resistant Organisms and Clostridium difficile with Prolonged Systemic Antibiotic Prophylaxis for Central Nervous System Devices.

Authors:  Stephanie Chauv; Gabriel V Fontaine; Quang P Hoang; Courtney B McKinney; Margaret Baldwin; Whitney R Buckel; Dave S Collingridge; Sarah Majercik; Paul D Wohlt
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

2.  Ventriculostomy-related infections: The performance of different definitions for diagnosing infection.

Authors:  Ariane Lewis; Sarah Wahlster; Sarah Karinja; Barry M Czeisler; W Taylor Kimberly; Aaron S Lord
Journal:  Br J Neurosurg       Date:  2015-09-15       Impact factor: 1.596

3.  Efficacy of translamina terminalis ventriculostomy tube in prevention of chronic hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Ahmed Abdelaziz Elsharkawy; Essam Ahmed Abdelhameed
Journal:  Surg Neurol Int       Date:  2020-09-12

4.  Discontinuation of Postoperative Prophylactic Antibiotics After Noninstrumented Spinal Surgery: Results of a Quality Improvement Project.

Authors:  Ariane Lewis; Jessica Lin; Herbert James; Travis C Hill; Rajeev Sen; Donato Pacione
Journal:  Neurohospitalist       Date:  2018-01-21

5.  The risk factors of intracranial infection in patients with intracerebral hemorrhage undergone hematoma puncture: what should we care.

Authors:  Haijing Han; Yu Li; Li Liu; Ningning Liu; Ying Wang; Min Zhang
Journal:  BMC Infect Dis       Date:  2020-12-11       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.